Reply by Authors.

Abstract

No AccessJournal of UrologyAdult Urology1 Mar 2021Reply by Authorsis a reply to letterEditorial Comment Steven Rosenberg, Marc Bonten, Wouter Haazen, Bart Spiessens, Darren Abbanat, Oscar Go, Florian Wagenlehner, Neal Shore, Yosuke Hagiwara, Patricia Ibarra de Palacios, Jeroen Geurtsen, Peter Hermans, and Jan Poolman Steven RosenbergSteven Rosenberg The Iowa Clinic, West Des Moines, Iowa More articles by this author , Marc BontenMarc Bonten Julius Center, UMC Utrecht, Utrecht, Netherlands Financial and/or other relationship with Janssen Pharmaceuticals. Financial and/or other relationship with Janssen Vaccines & Prevention. More articles by this author , Wouter HaazenWouter Haazen Janssen Research & Development, Beerse, Belgium More articles by this author , Bart SpiessensBart Spiessens Janssen Research & Development, Beerse, Belgium More articles by this author , Darren AbbanatDarren Abbanat Janssen Research & Development LLC, Raritan, New Jersey More articles by this author , Oscar GoOscar Go Janssen Research & Development LLC, Raritan, New Jersey More articles by this author , Florian WagenlehnerFlorian Wagenlehner Clinic for Urology, Pediatric Urology and Andrology, Justus-Liebig University, Giessen, Germany Financial and/or other relationship with Janssen Pharmaceuticals. More articles by this author , Neal ShoreNeal Shore Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, South Carolina Financial and/or other relationship with Janssen Pharmaceuticals. More articles by this author , Yosuke HagiwaraYosuke Hagiwara Janssen Pharmaceutical K.K., Tokyo, Japan More articles by this author , Patricia Ibarra de PalaciosPatricia Ibarra de Palacios Janssen Vaccines, Bern, Switzerland More articles by this author , Jeroen GeurtsenJeroen Geurtsen Janssen Vaccines & Prevention B.V., Leiden, Netherlands More articles by this author , Peter HermansPeter Hermans Julius Center, UMC Utrecht, Utrecht, Netherlands More articles by this author , and Jan PoolmanJan Poolman ‡Correspondence: Janssen Vaccines & Prevention B.V., Archimedesweg 4-6, 2333 CN, Leiden , The Netherlands telephone: +31 715197626; mobile: +31 631917392; E-mail Address: [email protected] Janssen Vaccines & Prevention B.V., Leiden, Netherlands More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001425.02AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Reply by Authors." The Journal of Urology, 205(3), p. 832 Reference 1. : Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: summary of data reported to the National Healthcare Safety Network, 2015–2017. Infect Control Hosp Epidemiol 2020; 41: 1. Google Scholar This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology5 Jan 2021Editorial Comment Volume 205Issue 3March 2021Page: 832-832 Advertisement Copyright & PermissionsCopyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.MetricsAuthor Information Steven Rosenberg The Iowa Clinic, West Des Moines, Iowa More articles by this author Marc Bonten Julius Center, UMC Utrecht, Utrecht, Netherlands Financial and/or other relationship with Janssen Pharmaceuticals. Financial and/or other relationship with Janssen Vaccines & Prevention. More articles by this author Wouter Haazen Janssen Research & Development, Beerse, Belgium More articles by this author Bart Spiessens Janssen Research & Development, Beerse, Belgium More articles by this author Darren Abbanat Janssen Research & Development LLC, Raritan, New Jersey More articles by this author Oscar Go Janssen Research & Development LLC, Raritan, New Jersey More articles by this author Florian Wagenlehner Clinic for Urology, Pediatric Urology and Andrology, Justus-Liebig University, Giessen, Germany Financial and/or other relationship with Janssen Pharmaceuticals. More articles by this author Neal Shore Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, South Carolina Financial and/or other relationship with Janssen Pharmaceuticals. More articles by this author Yosuke Hagiwara Janssen Pharmaceutical K.K., Tokyo, Japan More articles by this author Patricia Ibarra de Palacios Janssen Vaccines, Bern, Switzerland More articles by this author Jeroen Geurtsen Janssen Vaccines & Prevention B.V., Leiden, Netherlands More articles by this author Peter Hermans Julius Center, UMC Utrecht, Utrecht, Netherlands More articles by this author Jan Poolman Janssen Vaccines & Prevention B.V., Leiden, Netherlands ‡Correspondence: Janssen Vaccines & Prevention B.V., Archimedesweg 4-6, 2333 CN, Leiden , The Netherlands telephone: +31 715197626; mobile: +31 631917392; E-mail Address: [email protected] More articles by this author Expand All Advertisement PDF downloadLoading ...